DONALD YEE to Child
This is a "connection" page, showing publications DONALD YEE has written about Child.
Connection Strength
0.299
-
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
Score: 0.032
-
Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
Score: 0.031
-
The bottom (central) line in pediatric DVT. Blood. 2016 10 06; 128(14):1785-1786.
Score: 0.030
-
Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients. Clin Pharmacokinet. 2013 Nov; 52(11):967-80.
Score: 0.024
-
Evaluation of weight-based dosing of unfractionated heparin in obese children. J Pediatr. 2013 Jul; 163(1):150-3.
Score: 0.023
-
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.
Score: 0.022
-
Focus on diagnosis: a primer on D-dimer. Pediatr Rev. 2011 Jan; 32(1):31-3.
Score: 0.020
-
Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialists. Pediatr Blood Cancer. 2009 Dec; 53(6):960-6.
Score: 0.018
-
Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease. Arch Pathol Lab Med. 2005 Jun; 129(6):760-5.
Score: 0.013
-
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan; 7(1):e18-e27.
Score: 0.009
-
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119(5):844-853.
Score: 0.009
-
Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A. Thromb Haemost. 2017 08 30; 117(9):1705-1713.
Score: 0.008
-
Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism. Pediatr Blood Cancer. 2017 Nov; 64(11).
Score: 0.008
-
Pediatric Acquired von Willebrand Syndrome in Cardiopulmonary Disorders: Do Laboratory Abnormalities Predict Bleeding Risk? J Pediatr Hematol Oncol. 2017 03; 39(2):121-125.
Score: 0.008
-
Validation Study of the Composite Score to Identify Von Willebrand Disease in Children. J Pediatr Hematol Oncol. 2016 Mar; 38(2):139-42.
Score: 0.007
-
Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities. Blood. 2015 Dec 10; 126(24):2541-7.
Score: 0.007
-
Oral Tranexamic Acid versus Combined Oral Contraceptives for Adolescent Heavy Menstrual Bleeding: A Pilot Study. J Pediatr Adolesc Gynecol. 2015 Aug; 28(4):254-7.
Score: 0.007
-
Hemostatic abnormalities in young females with heavy menstrual bleeding. J Pediatr Adolesc Gynecol. 2014 Dec; 27(6):324-9.
Score: 0.006
-
Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis? Pediatr Blood Cancer. 2014 Nov; 61(11):2074-6.
Score: 0.006
-
FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1049-54.
Score: 0.005
-
A practical approach to pediatric patients referred with an abnormal coagulation profile. Arch Pathol Lab Med. 2005 Aug; 129(8):1011-6.
Score: 0.003
-
Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol. 2003 Apr; 25(4):336-9.
Score: 0.003